Akero Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
15 Jun 2023	Form 4/A: Graham G. Walmsley, Director Bought 400,000 shares ($10.4M) · Bought 120,000 shares ($5.04M)
27 Oct 2022	Form 4/A: Rolph Timothy, Chief Scientific Officer Received 10,000 shares by exercise or conversion ($63.6K) · Sold 22,500 shares ($657K)
02 Mar 2022	Form 4/A: Cheng Andrew, Director Holds 308,996 shares of Common Stock
10 Jul 2020	Form 4/A: Versant Venture Capital VI, L.p., 10% owner and 2 others Sold 14,162 shares ($284K) · Sold 22,368 shares ($443K) · Sold 16,527 shares ($334K)
10 Jul 2020	Form 4/A: Versant Venture Capital VI, L.p., 10% owner and 2 others Sold 15,852 shares ($323K) · Disposed of 709,629 shares (Other Transaction) · Acquired 25,486 shares (Other Transaction) · 2 more
31 Dec 2019	Form 4/A: Versant Venture Capital VI, L.p., 10% owner Sold 33,256 shares ($751K) · Sold 338,919 shares ($8.27M) · Sold 17,207 shares ($404K)

Comments